Technology
- Inquiry and RFP intakeForms and CRM routing so RFIs and sample requests reach the right person fast.
Home / Digital marketing / Industries / Life sciences
Life sciences · APIs, CDMOs and CMOs · USA, Canada and other markets
PromotEdge International works as a life science marketing agency for API manufacturers, contract development and manufacturing organizations (CDMOs), contract manufacturers and biotech suppliers selling to buyers in the USA, Canada and other markets. We build websites, technical content and B2B search around how sponsors shortlist suppliers, and keep every regulatory claim accurate. Our delivery team is in India.
On the shortlist when sponsors and buyers research suppliers, long before the RFP.
In short
Sponsors and procurement teams research suppliers for months before they issue an RFP. They look for capabilities, quality systems and regulatory history. We make those easy to find and impossible to misread.
Life science clients we have worked for include Kopran and Novozymes. That work was for their business in India and was delivered by our team there.
Most plans start with the website and capability content, then add search and LinkedIn.
Grouped by kind of work. Pick one, or ask us which to start with.
Brands we have worked with
Work delivered from India. Results are shared one to one, under NDA.
Active ingredient makers selling to formulators and generic companies abroad.
Contract development and manufacturing partners competing for sponsor shortlists.
Ingredients and technologies sold on science and application data.
Suppliers building trust with US and Canadian buyers who check regulatory history first.
We use these details only to reply to you.
Rather talk now?
A rough note through the form on what you sell and what needs to change.
How people find you today, where inquiries get lost, then a call in your working day.
The work, who does it and how it is measured. Nothing starts until you approve it.
Our team in India does the work, with calls set in your working hours.
Every number we report shows its source and date range, and we travel to our clients every 3 to 4 months.
Typical situations, not results from a named client. None of this is legal advice.
The US FDA does not 'approve' manufacturing plants, so 'FDA-approved facility' is wrong. We write 'FDA-inspected' or 'registered' only where true, with the date, and DMF or EU CEP claims only with proof.
GMP claims follow 21 CFR parts 210 and 211 in the USA and EU GMP in Europe. We describe your quality system as your documents show it, and your regulatory team approves every page.
An API maker cannot claim what a finished medicine does. We describe the ingredient and its specifications, never a treatment outcome.
DEA List I chemicals are never marketed loosely, and Health Canada licenses such as a Drug Establishment Licence are mentioned only if held.
Sponsors research for months before they contact anyone. Content and search keep you visible through that time.
Sponsors and procurement teams search for capabilities, molecules and services, read supplier websites closely, and check regulatory and quality history before they shortlist. Many decide who receives an RFP long before they speak to a sales team.
So the work starts with your capabilities, your quality documents and the questions sponsors ask. We build pages and content for those, keep every regulatory claim exact, and measure RFIs and inquiries by source.
There is no public price list, because the cost follows the job.
Any ad spend is separate and goes directly to the platforms. You see the scope and the fee in writing before work starts.
It helps API makers, CDMOs, CMOs and biotech suppliers reach sponsors and buyers through websites, technical content, B2B search, LinkedIn and inquiry handling, with regulatory claims kept accurate.
Yes. For CDMOs and CMOs we build capability and facility pages, content for sponsors and LinkedIn campaigns for sourcing roles, so you reach shortlists before RFPs go out.
Yes, for companies selling to other businesses: API makers, contract manufacturers and suppliers. We do not market medicines to patients; for practices and clinics, see our healthcare marketing agency page.
No, because the FDA does not approve plants. We can say 'FDA-inspected' or 'registered' if true, with the date your documents show. This is general information, not legal advice.
Every page with a regulatory, quality or technical claim goes to your regulatory team before it is published. We keep a record of which document backs each claim, so later updates are quick to check.
Yes. We build event landing pages, pre-show LinkedIn campaigns and follow-up emails, and log every contact from the event in your CRM so sales can follow up.
Shivanand Mishra, our Digital Marketing Lead, leads life science marketing, and your scientists and regulatory team check every technical fact.
A real person reads every message and replies.
Biotech companies sell science to people who understand it better than most marketers ever will. A platform company needs pharma partners, a tools company needs labs to adopt its method, a service company needs sponsors to trust it with programs, and a therapeutics company needs partners and investors without making claims FDA forbids. This guide sets out a biotech marketing strategy for each, with the limits on promotion. It is general information, not legal or regulatory advice. It sits under our main guide to CDMO marketing strategy, next to our life science marketing strategy guide.
A contract development and manufacturing organization is chosen in a meeting the CDMO is not invited to: the sponsor's sourcing, CMC and quality people narrow a long list to three or four names, and only then send a request for proposal. CDMO marketing strategy is the work of being on that short list, with capability pages that answer the sponsor's questions exactly, content that shows your scientists' judgment, and regulatory wording that a quality auditor would sign. This guide sets out the rules that govern the words, then the plan, and links to four spokes on the RFP, content, search and the website. It is the main guide in our life sciences series and sits beside our life sciences industry page. It is general information, not legal or regulatory advice; your quality and regulatory teams decide what you may say.
An RFP from a sponsor means the CDMO is already on a short list. What happens next is a scored comparison of three or four providers, read by sourcing, CMC, quality and project management, each looking for different answers to the same question: can this provider do this molecule, on this timeline, at this quality, with people we trust? This guide sets out how to answer it, from the decision to bid to the debrief, with the regulatory wording that a sponsor's quality auditor will check. It sits under our main guide to CDMO marketing strategy. It is general information, not legal or regulatory advice.
In life sciences, a buyer's first impression of a supplier is often a piece of content: an application note a development scientist found while solving a problem, a regulatory explainer forwarded by a CMC lead, a case summary a sourcing manager saved for a short list. Life science content marketing is the discipline of making that first impression correct, specific and worth remembering. This guide covers who reads it, the formats that earn trust, the review process that keeps it accurate, how to use AI without damaging trust, distribution and measurement. It sits under our main guide to CDMO marketing strategy.
Suppliers to pharmaceutical, biotech and diagnostics companies sell to people who check everything: a scientist who needs the material to perform, a quality team that needs it documented, a regulatory team that needs it filed, and procurement that needs a second source. Marketing that works for them is precise, technical and careful with regulatory words. This guide sets out a life science marketing strategy for B2B suppliers, from positioning to measurement, with the claims rules that matter most. It is general information, not legal or regulatory advice. It sits under our main guide to CDMO marketing strategy.
A sponsor's development team rarely searches for a CDMO's name. It searches for what it needs: a containment level, a process, a scale, an analytical method, a regulatory path. Life science SEO is the work of being the page those searches find, written in the searcher's words, organized by capability and site, technically sound and trusted enough to be cited when an AI summary answers instead. This guide covers what life science buyers search, the page map that answers them, the technical basics, content and AI summaries, regulatory wording and measurement. It sits under our main guide to CDMO marketing strategy.
Four kinds of work. One plan.